1. Home
  2. AGX vs TLX Comparison

AGX vs TLX Comparison

Compare AGX & TLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Argan Inc.

AGX

Argan Inc.

HOLD

Current Price

$570.94

Market Cap

6.2B

ML Signal

HOLD

Logo Telix Pharmaceuticals Limited American Depositary Shares

TLX

Telix Pharmaceuticals Limited American Depositary Shares

HOLD

Current Price

$9.24

Market Cap

2.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AGX
TLX
Founded
1961
2015
Country
United States
Australia
Employees
N/A
N/A
Industry
Engineering & Construction
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.2B
2.2B
IPO Year
1995
N/A

Fundamental Metrics

Financial Performance
Metric
AGX
TLX
Price
$570.94
$9.24
Analyst Decision
Buy
Strong Buy
Analyst Count
6
4
Target Price
$409.50
$21.13
AVG Volume (30 Days)
481.9K
250.6K
Earning Date
03-26-2026
04-17-2026
Dividend Yield
0.37%
N/A
EPS Growth
58.37
N/A
EPS
9.74
N/A
Revenue
$944,606,000.00
N/A
Revenue This Year
$28.94
N/A
Revenue Next Year
$18.64
N/A
P/E Ratio
$55.44
$150.33
Revenue Growth
8.06
N/A
52 Week Low
$111.16
$6.28
52 Week High
$588.00
$19.93

Technical Indicators

Market Signals
Indicator
AGX
TLX
Relative Strength Index (RSI) 64.90 63.49
Support Level $207.25 $8.85
Resistance Level N/A $9.92
Average True Range (ATR) 35.45 0.27
MACD 8.01 0.08
Stochastic Oscillator 89.11 80.87

Price Performance

Historical Comparison
AGX
TLX

About AGX Argan Inc.

Argan Inc is a United States-based construction firm that conducts operations through its wholly-owned subsidiaries, GPS, APC, TRC, and SMC. Through GPS and APC it provides a full range of engineering, procurement, construction, commissioning, maintenance, project development and technical consulting services to the power generation market, including the renewable energy sector, for a wide range of customers, including independent power project owners, public utilities, power plant heavy equipment suppliers and other commercial firms with power requirements in the U.S., Ireland and the U.K. It operates in three segments: Power Services, Industrial Services, and Telecom Services, out of which Power Services derives the majority of revenue.

About TLX Telix Pharmaceuticals Limited American Depositary Shares

Telix develops radiopharmaceuticals to manage cancer. Radiopharmaceuticals are radioisotopes bound to molecules that can target specific cells. At low doses, these drugs can bind to specific cancer cells with radiation, and then positron emission tomography imaging can accurately visualize tumors. At high doses, these drugs can selectively target and treat tumors with radiation, known as radioligand therapy. Radiopharmaceuticals are usually injected into the bloodstream. Telix has a pipeline of potential radiopharmaceuticals but currently earns most of its revenue from US sales of Illuccix, largely used as an imaging agent to visualize the spread of prostate cancer.

Share on Social Networks: